Type I interferon signature in the initiation of the immune response in vitiligo - Test2 - elhamkhani - TriplyDB

Type I interferon signature in the initiation of the immune response in vitiligo

Type I interferon signature in the initiation of the immune response in vitiligo

http://www.wikidata.org/entity/Q56996562

about

The STING pathway and the T cell-inflamed tumor microenvironment Molecular Pathways: Targeting the Stimulator of Interferon Genes (STING) in the Immunotherapy of Cancer Vitiligo blood transcriptomics provides new insights into disease mechanisms and identifies potential novel therapeutic targets.Accelerating bleaching in vitiligo: balancing benefits versus risks.Vitiligo: An Update on Pathophysiology and Treatment Options.Update on the role of plasmacytoid dendritic cells in inflammatory/autoimmune skin diseases.Understanding mechanisms of autoimmunity through translational research in vitiligo.HSP70 potentiates interferon-alpha production by plasmacytoid dendritic cells: relevance for cutaneous lupus and vitiligo pathogenesis.STING-mediated DNA sensing in cancer immunotherapy.Vitiligo: Focus on Clinical Aspects, Immunopathogenesis, and Therapy.HELZ2 Is an IFN Effector Mediating Suppression of Dengue Virus.Plasmacytoid Dendritic Cells and Type I Interferon Signature in Lichen Striatus.Suction blistering the lesional skin of vitiligo patients reveals useful biomarkers of disease activity.Vitiligo and lupus: more similarities than meets the eye.Autoimmunity and autoimmune co-morbidities in psoriasis.CXCL-10 and Interleukin-6 are reliable serum markers for vitiligo activity: A multicenter cross-sectional study.Comment: The mystery of melanocyte demise in vitiligo.Improved in vitro and in vivo activity against CD303-expressing targets of the chimeric 122A2 antibody selected for specific glycosylation pattern.Vitiligo

P2860

Q27008371-6464855C-9140-43D5-8BA9-06EDF4E1B8BF Q28080773-BF16778C-EA21-4E55-A6E9-480137236C96 Q37611016-26897798-B5E3-4AFF-8CCD-3EE5E77D915C Q38231335-922C3EEF-3143-4E21-953D-0CC4B4768E04 Q38675361-1FF37284-530E-49CC-8F44-9F1FD750DF93 Q38720050-3433225C-994A-468A-ACB3-5976C1514E5D Q38808662-0BDA6B4B-50AC-4BC8-9804-EB6FC3B04248 Q38852458-00D62100-0096-437C-AC22-D60A399CBB8A Q39389951-B0F3B83A-B197-4A1E-A568-4976B5D8CD1D Q39419931-F312A6B9-9CD0-4620-B96C-0D484B5535D1 Q40066511-0287E409-61D9-44C3-B8FB-DE5FC6F0FCC8 Q40770157-AD20F1E5-EE9E-471D-B51E-C2D8912A2908 Q46312769-89D02A33-7229-4547-A602-EBC731A64991 Q48204322-F17D499B-3F19-4335-9BF3-105F7A8FA26A Q48283379-43A1A755-DB01-4D50-BEB5-8BA7EAA4A80D Q48377795-11A43BBC-5B6B-4068-B0C1-C570C64DBD69 Q51062452-4F1F9249-8443-45B3-AF63-6E7AD9134866 Q52648918-D271DDC7-12EF-4B54-B612-A0E77838ABDE Q56996499-4139BB30-45D1-4482-9D8B-374F0CB17411

P2860

Type I interferon signature in the initiation of the immune response in vitiligo

http://www.wikidata.org/entity/Q56996562

description

article

@en

im Februar 2014 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в лютому 2014

@uk

name

Type I interferon signature in the initiation of the immune response in vitiligo

@en

Type I interferon signature in the initiation of the immune response in vitiligo

@nl

type

label

Type I interferon signature in the initiation of the immune response in vitiligo

@en

Type I interferon signature in the initiation of the immune response in vitiligo

@nl

prefLabel

Type I interferon signature in the initiation of the immune response in vitiligo

@en

Type I interferon signature in the initiation of the immune response in vitiligo

@nl

P1433

Q56996562-E3DEE8CA-600E-4982-8EA2-C00738CC0302

P1476

Q56996562-9ED0D374-A2AF-47D5-9613-A9E92B2824FE

P2093

Q56996562-2BCB0B44-033E-4606-9DAE-C43E83FDF0EF

Q56996562-3B690C8E-470C-495D-8740-09936D41D9B9

Q56996562-4E92FB97-A16D-4138-8786-EC1B596FD3DE

Q56996562-50583EA8-0507-4F44-BD22-5673E4CC8EBB

P2860

Q56996562-0279C79C-65E6-4994-B1E9-DD71279EA69B

Q56996562-0B45FB77-B522-4D71-B818-BAA7FE10B121

Q56996562-16CEB960-EC9C-460A-BB7F-4A92B1B11F56

Q56996562-18608F5F-646F-4A39-BF57-AF16CF979129

Q56996562-1A83847A-846E-4BD9-ADD1-E608D459B9DE

Q56996562-2E652ED1-FFF6-46BB-A756-674A32CD9536

Q56996562-315B436B-3829-456C-895C-3DC00103DEDB

Q56996562-3A273F64-FCA2-49EB-886E-A45B02F40DC2

Q56996562-3FD2E6B0-3EEB-4F16-9931-B1CDE395F807

Q56996562-48863EC2-69D1-421C-8317-416C58531935

P304

Q56996562-EBC07B1F-595F-4271-993F-36FE6FA2680B

P31

Q56996562-1955E9DF-E69C-4C1B-B12A-A7F8B90AEEBE

P356

Q56996562-2FF30AD4-71F1-4220-92D5-59A1E5EAACB3

P433

Q56996562-DCC0DA2A-01DD-40AD-97E6-6F6F443EA7FA

P478

Q56996562-F83B164F-CD60-4CBF-9942-F7B60B5AEC3D

P50

Q56996562-5C0D3C29-5824-4AD8-A9AD-1AE18E8C7E1E

Q56996562-83F4C2B0-842E-4128-959A-F8EC374A4114

Q56996562-C2286A93-5DD4-4D75-808D-4628F978AB5C

P577

Q56996562-6777232C-73A7-4093-8E3D-5B39D79A670D

P698

Q56996562-B5680E41-396C-4793-8108-0FAFC4404DDC

P356

P1433

Pigment Cell & Melanoma Research

P1476

Type I interferon signature in the initiation of the immune response in vitiligo

@en

P2093

Alain Taieb

http://www.w3.org/2001/XMLSchema#string

Antoine Bertolotti

http://www.w3.org/2001/XMLSchema#string

Beatrice Vergier

http://www.w3.org/2001/XMLSchema#string

Djavad Mossalayi

http://www.w3.org/2001/XMLSchema#string

P2860

Nucleic Acid sensors and type I interferon production in systemic lupus erythematosus

Variant of TYR and autoimmunity susceptibility loci in generalized vitiligo

A central role for inducible heat-shock protein 70 in autoimmune vitiligo

Interferons in Sjögren's Syndrome: Genes, Mechanisms, and Effects

NALP1 in vitiligo-associated multiple autoimmune disease.

Global activation of CD8+ cytotoxic T lymphocytes correlates with an impairment in regulatory T cells in patients with generalized vitiligo

Genome-wide analysis identifies a quantitative trait locus in the MHC class II region associated with generalized vitiligo age of onset

On the etiology of contact/occupational vitiligo.

Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production.

Induction of Vitiligo-Like Hypopigmentation after Imiquimod Treatment of Extramammary Paget's Disease

P304

398-407

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/PCMR.12219

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P50

Khaled Ezzedine

Julien Seneschal

P577

2014-02-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24438589

http://www.w3.org/2001/XMLSchema#string